Asher Biotherapeutics IPO

asherbio.com

Asher Bio is a biotech company developing precisely targeted immunotherapies for cancer and other diseases.

Founded2019
Total Funding to Date$166.65MM
Register for Details

For more details on financing and valuation for Asher Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Asher Biotherapeutics Ticker Symbol

Asher Biotherapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Asher Biotherapeutics Stock Price

The stock price for Asher Biotherapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Asher Biotherapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/1/2021 Series B $108MM raised $XXX.XX $XXX.XX
3/23/2021 Series A $55MM raised $XXX.XX $XXX.XX
8/19/2019 Series Seed-1, Seed-2, and Seed-3 $3.65MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Asher Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector